Uzbekistan Pharmaceuticals and Healthcare Report Q2 2016

BMI Industry View

Table: Headline Pharmaceuticals & Healthcare Forecasts (Uzbekistan 2014-2020)

SWOT

Industry Forecast

Pharmaceutical Market Forecast

Table: Pharmaceutical Sales, Historical Data And Forecasts (Uzbekistan 2012-2020)

Healthcare Market Forecast

Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)

Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)

Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Uzbekistan 2012-2020)

Prescription Drug Market Forecast

Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)

Patented Drug Market Forecast

Table: Patented Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)

Generic Drug Market Forecast

Table: Generic Drug Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)

OTC Medicine Market Forecast

Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Uzbekistan 2012-2020)

Pharmaceutical Trade Forecast

Table: Pharmaceutical Trade Data And Forecasts (Uzbekistan 2014-2020)

Table: Pharmaceutical Trade Data And Forecasts local currency (Uzbekistan 2014-2020)

Industry Risk/Reward Index

Central And Eastern Europe Risk/Reward Index

Uzbekistan Risk/Reward Index

Rewards

Risks

Regulatory Review

Counterfeit Drugs

Intellectual Property Issues

Pricing And Reimbursement

Market Overview

Healthcare Sector

Healthcare Provision

Health Insurance Sector

Healthcare Sector Reforms

Research And Development

Clinical Trials

International Cooperation

Epidemiology

Competitive Landscape

Research-Based Industry

Table: Multinational Market Activity

Generic Drugmakers

Leading Domestic Players

Table: List Of Companies In Uzpharmsanoat SJSC (as of October 7 2013)

Pharmaceutical Sector Reforms

Foreign Pharmaceutical Industry

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

Asklepiy Pharmaceutical Company

Jurabek Laboratories

Uzpharmsanoat

Demographic Forecast

Table: Population Headline Indicators (Uzbekistan 1990-2025)

Table: Key Population Ratios (Uzbekistan 1990-2025)

Table: Urban/Rural Population & Life Expectancy (Uzbekistan 1990-2025)

Table: Population By Age Group (Uzbekistan 1990-2025)

Table: Population By Age Group % (Uzbekistan 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview

Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Uzbekistan Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Non-communicable conditions will remain the leading contributors to Uzbekistan's burden of disease. Nevertheless, the country will be challenged in managing a tuberculosis epidemic and improving its relatively poor prognosis for infectious diseases control. Pharmaceutical companies with drug portfolios addressing both infectious diseases and chronic diseases will see commercial opportunities arise in Uzbekistan. However, we expect that this will be moderated by the low affordability of pharmaceuticals and the limited capacity of the Uzbek healthcare system to purchase medicines.

Headline Expenditure Projections

Pharmaceuticals: UZS2.78trn (USD956mn) in 2015 to UZS3.43trn (USD1.14bn) in 2016; 23.1% in local currency terms and 19.7% in US dollar terms. Forecast in US dollar terms revised upwards compared to the previous quarter.

Healthcare: UZS10.7trn (USD4.17bn) in 2015 to UZS12.8trn (USD4.27bn) in 2016; 19.2% in local currency terms and 2.2% in US dollar terms. Forecast in local currency terms revised upwards compared to the previous quarter.